End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9.18 CNY | +0.22% | +3.73% | +2.11% |
Apr. 15 | Luyan Pharma Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
2023 | Luyan Pharma Co.,Ltd. Announces Board Appointments | CI |
Sales 2022 | 19.46B 2.69B | Sales 2023 | 19.85B 2.75B | Capitalization | 3.49B 483M |
---|---|---|---|---|---|
Net income 2022 | 345M 47.75M | Net income 2023 | 364M 50.38M | EV / Sales 2022 | 0.4 x |
Net Debt 2022 | 4.49B 621M | Net Debt 2023 | 4.25B 588M | EV / Sales 2023 | 0.39 x |
P/E ratio 2022 |
9.36
x | P/E ratio 2023 |
9.56
x | Employees | 5,475 |
Yield 2022 |
3.6% | Yield 2023 |
3.34% | Free-Float | 57.22% |
1 day | +0.22% | ||
1 week | +3.73% | ||
Current month | +3.73% | ||
1 month | +11.27% | ||
3 months | +26.80% | ||
6 months | -2.86% | ||
Current year | +2.11% |
Managers | Title | Age | Since |
---|---|---|---|
Jin Xiang Wu
CEO | Chief Executive Officer | 62 | 08-08-31 |
Cong Jin Yang
DFI | Director of Finance/CFO | 55 | 11-10-19 |
Cui Ping Li
BRD | Director/Board Member | 44 | 11-10-19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Zhi Yang Lin
BRD | Director/Board Member | 68 | 17-10-18 |
Jin Xiang Wu
CEO | Chief Executive Officer | 62 | 08-08-31 |
Yan Zhao Tang
BRD | Director/Board Member | 56 | 17-10-18 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 9.18 | +0.22% | 4,186,174 |
24-05-09 | 9.16 | +1.55% | 5,789,135 |
24-05-08 | 9.02 | -0.22% | 4,974,951 |
24-05-07 | 9.04 | -0.33% | 5,009,548 |
End-of-day quote Shenzhen S.E., May 09, 2024
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+2.11% | 494M | |
+20.94% | 72.78B | |
-1.26% | 24.24B | |
+5.13% | 8.59B | |
+8.25% | 8.38B | |
-19.42% | 8.09B | |
+5.56% | 4.81B | |
+16.83% | 4.32B | |
-1.83% | 4.05B | |
+26.97% | 3.79B |
- Stock Market
- Equities
- 002788 Stock